Authors: Kraus, JA Wenghoefer, M Glesmann, N Mohr, S Beck, M Schmidt, MC Schroder, R Berweiler, U Roggendorf, W Diete, S Dietzmann, K Heuser, K Muller, B Fimmers, R von Deimling, A Schlegel, U

Citation: Ja. Kraus et al., TP53 gene mutations, nuclear p53 accumulation, expression of waf/p21, bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme, J NEURO-ONC, 52(3), 2001, pp. 263-272

Authors: Kraus, JA Lamszus, K Glesmann, N Beck, M Wolter, M Sabel, M Krex, D Klockgether, T Reifenberger, G Schlegel, U

Citation: Ja. Kraus et al., Molecular genetic alterations in glioblastomas with oligodendroglial component, ACT NEUROP, 101(4), 2001, pp. 311-320

Authors: Kraus, JA Glesmann, N Beck, M Krex, D Klockgether, T Schackert, G Schlegel, U

Citation: Ja. Kraus et al., Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme, J NEURO-ONC, 48(2), 2000, pp. 89-94